Dr. Daniel Dilling, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
2160 S First Ave, Fahey Bldg., Room 131a
Maywood, IL 60153
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 300
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
IL license 36104271 -
Pulmonary Disease Physician
IL license 36104271
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Northwestern Lake Forest Hospital Lake Forest, IL
- Saint Francis Medical Center Peoria, IL
- Loyola University Medical Center Maywood, IL
- Advocate Good Shepherd Hospital Barrington, IL
Medical groups
- Loyola University Medical Center (953 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 300
- Services billed
- 1,216
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Test to measure rate of airflow | 252 | 149 |
| Established patient office or other outpatient visit, 30-39 minutes | 183 | 120 |
| Established patient office or other outpatient visit, 40-54 minutes | 168 | 88 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 152 | 47 |
| Test to examine how well the lungs exchange gases | 49 | 48 |
| Test to determine lung volumes using sensors | 48 | 47 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 38 | 35 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | 20 |
| Hospital discharge day management, more than 30 minutes | 30 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ofev (nintedanib esylate) | 262 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Maywood, IL | 199 |
| Azithromycin Other prescribers in Maywood, IL | 168 |
| Prednisone Other prescribers in Maywood, IL | 168 |
| Mycophenolate Mofetil Other prescribers in Maywood, IL | 157 |
| Pantoprazole Sodium Other prescribers in Maywood, IL | 150 |
| Tacrolimus Other prescribers in Maywood, IL | 118 |
| Rosuvastatin Calcium Other prescribers in Maywood, IL | 92 |
| Amlodipine Besylate Other prescribers in Maywood, IL | 86 |
| Gabapentin Other prescribers in Maywood, IL | 79 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 53 payments worth $59,662 in total to this clinician.
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59,410 |
|---|---|
| Genentech USA, Inc. | $125 |
| United Therapeutics Corporation | $62.66 |
| Sanofi-aventis U.S. LLC | $28.24 |
| Kamada LTD. | $20.50 |
| AstraZeneca Pharmaceuticals LP | $16.03 |
| Compensation for services other than consulting (speaking, faculty) | $28,325 |
|---|---|
| Consulting Fee | $23,525 |
| Travel and Lodging | $6,141 |
| Food and Beverage | $1,671 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. May 20, 2025 | Consulting Fee | $10,080 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $7,920 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $6,375 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 23, 2025 | Consulting Fee OFEV · RESPIRATORY | $5,525 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $5,525 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,680 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,680 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $3,825 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 12, 2025 | Travel and Lodging travel to Peoria, IL · in-kind | $1,397 |
All 28 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $6,375 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 30, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Youngstown, OH · in-kind | $65.40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 23, 2025 | Consulting Fee OFEV · RESPIRATORY | $5,525 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $5,525 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $226 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Oak Brook, IL · in-kind | $33.60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $3,825 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Youngstown, OH · in-kind | $753 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Youngstown, OH · in-kind | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 20, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Springfield, IL · in-kind | $1,131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $30.11 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 7, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $227 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,680 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 20, 2025 | Consulting Fee | $10,080 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 20, 2025 | Travel and Lodging travel to Newton, MA · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 20, 2025 | Travel and Lodging travel to Oak Brook, IL · in-kind | $32.20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 12, 2025 | Travel and Lodging travel to Peoria, IL · in-kind | $1,397 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 30, 2025 | Travel and Lodging travel to Needham Heights, MA · in-kind | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 30, 2025 | Travel and Lodging travel to Needham Heights, MA · in-kind | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 17, 2025 | Travel and Lodging travel to Needham Heights, MA · in-kind | $16.55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $7,920 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 2, 2025 | Travel and Lodging travel to Needham Heights, MA · in-kind | $366 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 2, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 6, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 18, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $703 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,680 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 5 companies. The companies reported $331,044 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
E.r. Squibb & Sons, L.l.c. - Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
United Therapeutics Corporation · Enrolling by invitation · NCT04905693 - Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics Corporation · Recruiting · NCT05943535 - Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
United Therapeutics Corporation · Completed · NCT04708782 - A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
E.r. Squibb & Sons, L.l.c. - Idiopathic Pulmonary Fibrosis Prospective Outcome Registry
Boehringer Ingelheim Pharmaceuticals, Inc. - A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Sanofi US Services Inc. · Recruiting · NCT06082037 - Phase 2 Double Blind Randomized Study in IPF and SSc ILD
Genentech, Inc. - DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics Corporation · Recruiting · NCT06388421
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.